Weatherford Stock Rating Lowered by BMO Capital Markets (WFT)

Weatherford (NYSE: WFT) was downgraded by equities research analysts at BMO Capital Markets from a “market perform” rating to an “underperform” rating in a research note issued to investors on Monday.

Other equities research analysts have also recently issued reports about the stock. Analysts at TheStreet reiterated a “hold” rating on shares of Weatherford in a research note to investors on Monday, March 4th. Separately, analysts at Susquehanna cut their price target on shares of Weatherford from $13.00 to $12.00 in a research note to investors on Thursday, February 28th. They now have a “neutral” rating on the stock. Finally, analysts at Sterne Agee raised their price target on shares of Weatherford from $13.00 to $14.00 in a research note to investors on Thursday, February 28th. They now have a “buy” rating on the stock.

Shares of Weatherford traded down 1.69% during mid-day trading on Monday, hitting $11.61. Weatherford has a one year low of $8.84 and a one year high of $17.75. The stock’s 50-day moving average is currently $12.59. The company’s market cap is $8.883 billion.

Weatherford International Ltd. (Weatherford) is a provider of equipment and services used in the drilling, evaluation, completion, production and intervention of oil and natural gas wells.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.

Latest News

Google Spends $1 Billion To Purchase Waze
Google Spends $1 Billion To Purchase Waze
Apple Exploring Options In Net Radio
Apple Exploring Options In Net Radio
Taxpayers Pay Millions for Fed Workers Student Loan Relief
Taxpayers Pay Millions for Fed Workers Student Loan Relief
Aaron Hernandez, New England Patriots Player has House Searched
Aaron Hernandez, New England Patriots Player has House Searched
Supreme Court Allows Regulators to Challenge Generic Drug Agreements
Supreme Court Allows Regulators to Challenge Generic Drug Agreements
Car Sales in Europe Hit Record Lows
Car Sales in Europe Hit Record Lows


Leave a Reply

 
© 2010-2013 Zolmax.com, LLC.
Subscribe Subscribe